<?xml version="1.0" encoding="UTF-8"?>
<annotations textSource="phac-aspc-gc-ca_20160823T123914.txt">
    <annotation>
        <mention id="EHOST_Instance_3323" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="840" end="1059" />
        <spannedText>Adults born before 1970 can be presumed to have acquired natural immunity to measles; however, non-immune health care workers, travellers and military personnel should receive MMR vaccine, regardless of year of birth</spannedText>
        <creationDate>Tue Apr 03 05:37:59 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3323">
        <mentionClass id="claim">Adults born before 1970 can be presumed to have acquired natural immunity to measles; however, non-immune health care workers, travellers and military personnel should receive MMR vaccine, regardless of year of birth</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3324" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="1061" end="1321" />
        <spannedText>Routine childhood immunization: administer two doses of measles-containing vaccine (MMR or MMRV); the first dose at 12 to 15 months of age and the second dose at 18 months of age or any time thereafter, but should be given not later than around school entry</spannedText>
        <creationDate>Tue Apr 03 05:39:05 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3324">
        <mentionClass id="claim">Routine childhood immunization: administer two doses of measles-containing vaccine (MMR or MMRV); the first dose at 12 to 15 months of age and the second dose at 18 months of age or any time thereafter, but should be given not later than around school entry</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3325" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="1323" end="1432" />
        <spannedText>Children and adolescents who are previously unimmunized: administer two doses of measles-containing vaccine</spannedText>
        <creationDate>Tue Apr 03 05:39:11 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3325">
        <mentionClass id="claim">Children and adolescents who are previously unimmunized: administer two doses of measles-containing vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3326" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="1752" end="1828" />
        <spannedText>Susceptible adults born in 1970 or later: administer one dose of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 05:39:16 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3326">
        <mentionClass id="claim">Susceptible adults born in 1970 or later: administer one dose of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3327" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="1830" end="2076" />
        <spannedText>Those who are at the greatest risk of measles exposure (travellers to destinations outside of North America, health care workers, students in post-secondary educational settings, and military personnel) should receive two doses of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 05:41:02 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3327">
        <mentionClass id="claim">Those who are at the greatest risk of measles exposure (travellers to destinations outside of North America, health care workers, students in post-secondary educational settings, and military personnel) should receive two doses of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3328" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="2213" end="2288" />
        <spannedText>Non-immune travellers born before 1970: administer one dose of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 05:41:22 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3328">
        <mentionClass id="claim">Non-immune travellers born before 1970: administer one dose of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3329" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="2291" end="2375" />
        <spannedText>Non-immune students born before 1970: consider administering one dose of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 05:41:24 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3329">
        <mentionClass id="claim">Non-immune students born before 1970: consider administering one dose of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3330" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="2540" end="2584" />
        <spannedText>MMR and MMRV vaccines are safe and effective</spannedText>
        <creationDate>Tue Apr 03 05:41:31 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3330">
        <mentionClass id="claim">MMR and MMRV vaccines are safe and effective</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3331" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="8373" end="8575" />
        <spannedText>Two doses of measles-containing vaccine should be given for routine immunization of children and for immunization of children and adolescents who have missed measles immunization on the routine schedule</spannedText>
        <creationDate>Tue Apr 03 05:47:52 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3331">
        <mentionClass id="claim">Two doses of measles-containing vaccine should be given for routine immunization of children and for immunization of children and adolescents who have missed measles immunization on the routine schedule</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3332" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="9458" end="9785" />
        <spannedText>Students in post-secondary educational settings, born in 1970 or later, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 08:05:32 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3332">
        <mentionClass id="claim">Students in post-secondary educational settings, born in 1970 or later, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3333" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="9127" end="9438" />
        <spannedText>Health care workers, regardless of their year of birth, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 08:05:46 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3333">
        <mentionClass id="claim">Health care workers, regardless of their year of birth, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3334" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="8814" end="9123" />
        <spannedText>Adults without contraindications, born in 1970 or later who do not have documented evidence of receiving measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles infection should be immunized with one dose of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 08:05:53 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3334">
        <mentionClass id="claim">Adults without contraindications, born in 1970 or later who do not have documented evidence of receiving measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles infection should be immunized with one dose of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3335" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="9882" end="10192" />
        <spannedText>Military personnel, regardless of their year of birth, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 08:06:05 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3335">
        <mentionClass id="claim">Military personnel, regardless of their year of birth, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3336" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="10194" end="10540" />
        <spannedText>Travellers to destinations outside of North America, born in 1970 or later, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of measles-containing vaccine</spannedText>
        <creationDate>Tue Apr 03 08:06:15 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3336">
        <mentionClass id="claim">Travellers to destinations outside of North America, born in 1970 or later, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of measles-containing vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3337" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="10542" end="10812" />
        <spannedText>Travellers born before 1970 who do not have documented evidence of receiving a measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive one dose of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 08:06:23 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3337">
        <mentionClass id="claim">Travellers born before 1970 who do not have documented evidence of receiving a measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive one dose of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3338" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="10916" end="11156" />
        <spannedText>Children and adults lacking adequate documentation of immunization should be considered unimmunized and started on an immunization schedule appropriate for their age and risk factors, unless known to be immune based on laboratory testing</spannedText>
        <creationDate>Tue Apr 03 08:06:34 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3338">
        <mentionClass id="claim">Children and adults lacking adequate documentation of immunization should be considered unimmunized and started on an immunization schedule appropriate for their age and risk factors, unless known to be immune based on laboratory testing</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3339" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="11497" end="11656" />
        <spannedText>Immunity to measles, mumps and rubella should be reviewed in women of reproductive age, and vaccination should be recommended to non-pregnant susceptible women</spannedText>
        <creationDate>Tue Apr 03 08:06:51 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3339">
        <mentionClass id="claim">Immunity to measles, mumps and rubella should be reviewed in women of reproductive age, and vaccination should be recommended to non-pregnant susceptible women</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3340" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="11658" end="11801" />
        <spannedText>Ideally, the immunization status of women intending to become pregnant should be reviewed and vaccines updated as necessary prior to conception</spannedText>
        <creationDate>Tue Apr 03 08:06:58 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3340">
        <mentionClass id="claim">Ideally, the immunization status of women intending to become pregnant should be reviewed and vaccines updated as necessary prior to conception</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3341" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="11803" end="11893" />
        <spannedText>Women should delay pregnancy by at least 28 days following vaccination with a live vaccine</spannedText>
        <creationDate>Tue Apr 03 08:07:02 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3341">
        <mentionClass id="claim">Women should delay pregnancy by at least 28 days following vaccination with a live vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3342" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="11895" end="12124" />
        <spannedText>MMR and MMRV vaccines should generally not be given during pregnancy because of the theoretical risk of disease transmission to the fetus; however, there is no evidence demonstrating a teratogenic or other risk from such vaccines</spannedText>
        <creationDate>Tue Apr 03 08:07:14 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3342">
        <mentionClass id="claim">MMR and MMRV vaccines should generally not be given during pregnancy because of the theoretical risk of disease transmission to the fetus; however, there is no evidence demonstrating a teratogenic or other risk from such vaccines</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3343" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="12259" end="12509" />
        <spannedText>Inadvertent immunization with MMR vaccine is not a reason for pregnancy termination. In some situations, potential benefits of MMR vaccination may outweigh risks such as during measles or rubella outbreaks, in which case vaccination may be considered</spannedText>
        <creationDate>Tue Apr 03 08:08:28 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3343">
        <mentionClass id="claim">Inadvertent immunization with MMR vaccine is not a reason for pregnancy termination. In some situations, potential benefits of MMR vaccination may outweigh risks such as during measles or rubella outbreaks, in which case vaccination may be considered</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3344" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="12720" end="12911" />
        <spannedText>Susceptible residents of long-term care facilities should receive measles, mumps and rubella-containing vaccine as well as all routine immunizations appropriate for their age and risk factors</spannedText>
        <creationDate>Tue Apr 03 08:15:17 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3344">
        <mentionClass id="claim">Susceptible residents of long-term care facilities should receive measles, mumps and rubella-containing vaccine as well as all routine immunizations appropriate for their age and risk factors</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3345" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="13022" end="13153" />
        <spannedText>In general, immunocompromised persons should not receive live vaccines because of the risk of disease caused by the vaccine strains</spannedText>
        <creationDate>Tue Apr 03 08:15:27 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3345">
        <mentionClass id="claim">In general, immunocompromised persons should not receive live vaccines because of the risk of disease caused by the vaccine strains</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3346" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="13155" end="13325" />
        <spannedText>When considering immunization of an immunocompromised person with a live vaccine, approval from the individualís attending physician should be obtained before vaccination</spannedText>
        <creationDate>Tue Apr 03 08:15:34 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3346">
        <mentionClass id="claim">When considering immunization of an immunocompromised person with a live vaccine, approval from the individualís attending physician should be obtained before vaccination</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3347" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="13434" end="13775" />
        <spannedText>People who have a suspicious history for immunodeficiency disorders (e.g., known or suspected family history of congenital immunodeficiency disorder or HIV infection, or history of failure to thrive and recurrent infections) should not be immunized with a live vaccine until they have been fully investigated and T cell dysfunction ruled out</spannedText>
        <creationDate>Tue Apr 03 08:15:48 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3347">
        <mentionClass id="claim">People who have a suspicious history for immunodeficiency disorders (e.g., known or suspected family history of congenital immunodeficiency disorder or HIV infection, or history of failure to thrive and recurrent infections) should not be immunized with a live vaccine until they have been fully investigated and T cell dysfunction ruled out</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3348" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="14007" end="14134" />
        <spannedText>A history of negative prenatal screening of the infantís mother for HIV should be obtained before administering a live vaccine</spannedText>
        <creationDate>Tue Apr 03 08:16:17 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3348">
        <mentionClass id="claim">A history of negative prenatal screening of the infantís mother for HIV should be obtained before administering a live vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3349" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="14136" end="14263" />
        <spannedText>If a mother has not received routine prenatal care in Canada, the possibility of undiagnosed HIV infection should be considered</spannedText>
        <creationDate>Tue Apr 03 08:16:21 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3349">
        <mentionClass id="claim">If a mother has not received routine prenatal care in Canada, the possibility of undiagnosed HIV infection should be considered</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3350" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="14413" end="14597" />
        <spannedText>MMR vaccine, as appropriate for age, should be considered if the individual is not receiving regular immune globulin replacement therapy which may affect the efficacy of the vaccine</spannedText>
        <creationDate>Tue Apr 03 08:16:40 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3350">
        <mentionClass id="claim">MMR vaccine, as appropriate for age, should be considered if the individual is not receiving regular immune globulin replacement therapy which may affect the efficacy of the vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3351" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="16947" end="17121" />
        <spannedText>Serologic response should be checked after the first dose of MMR vaccine and a second dose should be given 3 months or more after the first dose if there is no seroconversion</spannedText>
        <creationDate>Tue Apr 03 08:17:43 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3351">
        <mentionClass id="claim">Serologic response should be checked after the first dose of MMR vaccine and a second dose should be given 3 months or more after the first dose if there is no seroconversion</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3352" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="17152" end="17320" />
        <spannedText>If possible, individuals being considered for solid organ transplantation should receive immunizations recommended for their age before the transplantation is performed</spannedText>
        <creationDate>Tue Apr 03 08:17:48 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3352">
        <mentionClass id="claim">If possible, individuals being considered for solid organ transplantation should receive immunizations recommended for their age before the transplantation is performed</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3353" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="17451" end="17588" />
        <spannedText>MMR vaccine should be given at least 4 weeks before solid organ transplantation and, in general, is not recommended after transplantation</spannedText>
        <creationDate>Tue Apr 03 08:18:02 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3353">
        <mentionClass id="claim">MMR vaccine should be given at least 4 weeks before solid organ transplantation and, in general, is not recommended after transplantation</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3354" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="17619" end="17841" />
        <spannedText>Vaccination status for measles, mumps and rubella should be reviewed for immunocompetent persons who might be anticipating initiation of immunosuppressive treatments or who have diseases that might lead to immunodeficiency</spannedText>
        <creationDate>Tue Apr 03 08:18:10 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3354">
        <mentionClass id="claim">Vaccination status for measles, mumps and rubella should be reviewed for immunocompetent persons who might be anticipating initiation of immunosuppressive treatments or who have diseases that might lead to immunodeficiency</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3355" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="17950" end="18125" />
        <spannedText>If indicated, MMR vaccine should be administered at least 4 weeks before the initiation of immunosuppressive therapy to reduce the risk of disease caused by the vaccine strain</spannedText>
        <creationDate>Tue Apr 03 08:18:24 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3355">
        <mentionClass id="claim">If indicated, MMR vaccine should be administered at least 4 weeks before the initiation of immunosuppressive therapy to reduce the risk of disease caused by the vaccine strain</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3356" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="18443" end="18578" />
        <spannedText>A period of at least 4 weeks should elapse between discontinuation of high-dose systemic steroids and the administration of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 08:19:48 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3356">
        <mentionClass id="claim">A period of at least 4 weeks should elapse between discontinuation of high-dose systemic steroids and the administration of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3357" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="19380" end="19545" />
        <spannedText>until additional information becomes available, avoidance of MMR vaccines during intermittent or low dose chemotherapy or other immunosuppressive therapy is prudent</spannedText>
        <creationDate>Tue Apr 03 08:19:51 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3357">
        <mentionClass id="claim">until additional information becomes available, avoidance of MMR vaccines during intermittent or low dose chemotherapy or other immunosuppressive therapy is prudent</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3358" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="20426" end="20499" />
        <spannedText>B cell enumeration should be normal before vaccination with live vaccines</spannedText>
        <creationDate>Tue Apr 03 08:20:16 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3358">
        <mentionClass id="claim">B cell enumeration should be normal before vaccination with live vaccines</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3359" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="20547" end="20626" />
        <spannedText>Vaccination status should be reviewed prior to commencing monoclonal antibodies</spannedText>
        <creationDate>Tue Apr 03 08:20:21 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3359">
        <mentionClass id="claim">Vaccination status should be reviewed prior to commencing monoclonal antibodies</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3360" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="20642" end="20762" />
        <spannedText>An infectious disease specialist/immunologist should be consulted for advice on MMR immunization in HIV-infected people</spannedText>
        <creationDate>Tue Apr 03 08:20:29 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3360">
        <mentionClass id="claim">An infectious disease specialist/immunologist should be consulted for advice on MMR immunization in HIV-infected people</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3361" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="21706" end="21850" />
        <spannedText>Susceptible household contacts of immunocompromised people should receive a measles-containing vaccine as appropriate for age and risk factors</spannedText>
        <creationDate>Tue Apr 03 08:21:00 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3361">
        <mentionClass id="claim">Susceptible household contacts of immunocompromised people should receive a measles-containing vaccine as appropriate for age and risk factors</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3362" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="21985" end="22204" />
        <spannedText>Hyposplenic or asplenic (congenital absence, surgical removal or functional [e.g., sickle cell disease]) individuals should be immune to measles, mumps and rubella or should receive MMR or MMRV vaccine as appropriate</spannedText>
        <creationDate>Tue Apr 03 08:21:17 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3362">
        <mentionClass id="claim">Hyposplenic or asplenic (congenital absence, surgical removal or functional [e.g., sickle cell disease]) individuals should be immune to measles, mumps and rubella or should receive MMR or MMRV vaccine as appropriate</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3363" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="22206" end="22369" />
        <spannedText>Individuals with chronic renal disease or undergoing dialysis should be immune to measles, mumps and rubella or should receive MMR or MMRV vaccine as appropriate</spannedText>
        <creationDate>Tue Apr 03 08:21:22 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3363">
        <mentionClass id="claim">Individuals with chronic renal disease or undergoing dialysis should be immune to measles, mumps and rubella or should receive MMR or MMRV vaccine as appropriate</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3364" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="22371" end="22586" />
        <spannedText>People with conditions such as autism spectrum disorders or demyelinating disorders (including multiple sclerosis) should receive all routinely recommended immunizations, including MMR or MMRV vaccine as appropriate</spannedText>
        <creationDate>Tue Apr 03 08:21:27 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3364">
        <mentionClass id="claim">People with conditions such as autism spectrum disorders or demyelinating disorders (including multiple sclerosis) should receive all routinely recommended immunizations, including MMR or MMRV vaccine as appropriate</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3365" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="22590" end="22803" />
        <spannedText>Individuals with autoimmune disease not being treated with immunosuppressive drugs are not considered significantly immunocompromised and should receive MMR immunization following consultation with their physician</spannedText>
        <creationDate>Tue Apr 03 08:21:36 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3365">
        <mentionClass id="claim">Individuals with autoimmune disease not being treated with immunosuppressive drugs are not considered significantly immunocompromised and should receive MMR immunization following consultation with their physician</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3366" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="23171" end="23470" />
        <spannedText>Travellers born in 1970 or later who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of measles-containing vaccine</spannedText>
        <creationDate>Tue Apr 03 08:22:05 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3366">
        <mentionClass id="claim">Travellers born in 1970 or later who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive two doses of measles-containing vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3367" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="23473" end="23595" />
        <spannedText>Measles vaccine should be given at an earlier age than usual for children travelling to countries outside of North America</spannedText>
        <creationDate>Tue Apr 03 08:22:10 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3367">
        <mentionClass id="claim">Measles vaccine should be given at an earlier age than usual for children travelling to countries outside of North America</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3368" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="23810" end="24077" />
        <spannedText>Travellers born before 1970, who do not have documented evidence of receiving measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive one dose of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 08:22:24 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3368">
        <mentionClass id="claim">Travellers born before 1970, who do not have documented evidence of receiving measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should receive one dose of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3369" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="24287" end="24432" />
        <spannedText>Health care providers who see persons newly arrived in Canada should review the immunization status and update immunization for these individuals</spannedText>
        <creationDate>Tue Apr 03 08:29:45 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3369">
        <mentionClass id="claim">Health care providers who see persons newly arrived in Canada should review the immunization status and update immunization for these individuals</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3370" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="24865" end="25222" />
        <spannedText>Health care workers, regardless of their year of birth, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should be vaccinated accordingly so that they have received two doses of MMR vaccine</spannedText>
        <creationDate>Tue Apr 03 08:33:06 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3370">
        <mentionClass id="claim">Health care workers, regardless of their year of birth, who do not have documented evidence of receiving two doses of measles-containing vaccine on or after their first birthday, or laboratory evidence of immunity, or a history of laboratory confirmed measles disease should be vaccinated accordingly so that they have received two doses of MMR vaccine</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3371" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="25400" end="25507" />
        <spannedText>For practical purposes, all individuals attending the same school or facility should be considered contacts</spannedText>
        <creationDate>Tue Apr 03 08:33:20 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3371">
        <mentionClass id="claim">For practical purposes, all individuals attending the same school or facility should be considered contacts</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3372" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="26077" end="26300" />
        <spannedText>Prophylactic use of Ig has been shown to be effective in modifying or preventing disease if administered within 6 days after exposure to measles, however, it should be given as soon as possible after exposure when indicated</spannedText>
        <creationDate>Tue Apr 03 08:33:39 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3372">
        <mentionClass id="claim">Prophylactic use of Ig has been shown to be effective in modifying or preventing disease if administered within 6 days after exposure to measles, however, it should be given as soon as possible after exposure when indicated</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3373" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="26302" end="26488" />
        <spannedText>Ig should be considered for contacts of measles who are: Measles-containing vaccine is contraindicated in groups 1 and 2 and effectiveness and safety has not been established in group 3</spannedText>
        <creationDate>Tue Apr 03 08:33:54 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3373">
        <mentionClass id="claim">Ig should be considered for contacts of measles who are: Measles-containing vaccine is contraindicated in groups 1 and 2 and effectiveness and safety has not been established in group 3</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3374" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="26490" end="26803" />
        <spannedText>Ig should also be considered for susceptible immunocompetent contacts of measles who are 6 months of age and older and who present more than 72 hours after exposure (when MMR vaccine no longer provides post-exposure protection) but within 6 days after exposure (when Ig may still provide post-exposure protection)</spannedText>
        <creationDate>Tue Apr 03 08:34:00 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3374">
        <mentionClass id="claim">Ig should also be considered for susceptible immunocompetent contacts of measles who are 6 months of age and older and who present more than 72 hours after exposure (when MMR vaccine no longer provides post-exposure protection) but within 6 days after exposure (when Ig may still provide post-exposure protection)</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3375" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="26947" end="27130" />
        <spannedText>A dose of Ig should be considered in HIV infected individuals with severe immunosuppression after a known exposure to confirmed measles, even with documented previous MMR immunization</spannedText>
        <creationDate>Tue Apr 03 08:34:11 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3375">
        <mentionClass id="claim">A dose of Ig should be considered in HIV infected individuals with severe immunosuppression after a known exposure to confirmed measles, even with documented previous MMR immunization</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3376" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="27132" end="27353" />
        <spannedText>Regardless of vaccination status pre-transplant, Ig should also be considered for hematopoietic stem cell transplantation (HSCT) recipients, unless vaccinated post HSCT and known to have an adequate measles antibody titre</spannedText>
        <creationDate>Tue Apr 03 08:34:17 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3376">
        <mentionClass id="claim">Regardless of vaccination status pre-transplant, Ig should also be considered for hematopoietic stem cell transplantation (HSCT) recipients, unless vaccinated post HSCT and known to have an adequate measles antibody titre</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3377" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="27904" end="28288" />
        <spannedText>Exposed individuals should be counseled regarding signs and symptoms of measles; counseling should include avoiding contact with others should they become ill with symptoms compatible with measles and the need to seek medical care, including advising health care workers of the possibility of measles before going to a health care setting so that appropriate precautions can be taken</spannedText>
        <creationDate>Tue Apr 03 08:34:44 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3377">
        <mentionClass id="claim">Exposed individuals should be counseled regarding signs and symptoms of measles; counseling should include avoiding contact with others should they become ill with symptoms compatible with measles and the need to seek medical care, including advising health care workers of the possibility of measles before going to a health care setting so that appropriate precautions can be taken</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3378" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="28657" end="28703" />
        <spannedText>A maximum dose of 15 mL should not be exceeded</spannedText>
        <creationDate>Tue Apr 03 08:34:54 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3378">
        <mentionClass id="claim">A maximum dose of 15 mL should not be exceeded</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3379" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="30267" end="30376" />
        <spannedText>MMR vaccine should be administered subcutaneously; MMRV can be administered subcutaneously or intramuscularly</spannedText>
        <creationDate>Tue Apr 03 08:36:01 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3379">
        <mentionClass id="claim">MMR vaccine should be administered subcutaneously; MMRV can be administered subcutaneously or intramuscularly</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3380" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="30500" end="30641" />
        <spannedText>For routine immunization of children aged 12 months to 12 years, two doses of measles-containing vaccine (MMR or MMRV) should be administered</spannedText>
        <creationDate>Tue Apr 03 08:36:07 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3380">
        <mentionClass id="claim">For routine immunization of children aged 12 months to 12 years, two doses of measles-containing vaccine (MMR or MMRV) should be administered</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3381" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="30643" end="30854" />
        <spannedText>The first dose of measles-containing vaccine should be administered at 12 to 15 months of age and the second dose at 18 months of age or any time thereafter, but should be given no later than around school entry</spannedText>
        <creationDate>Tue Apr 03 08:36:13 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3381">
        <mentionClass id="claim">The first dose of measles-containing vaccine should be administered at 12 to 15 months of age and the second dose at 18 months of age or any time thereafter, but should be given no later than around school entry</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3382" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="30931" end="31061" />
        <spannedText>Children who previously received a single dose of MMR vaccine should receive a second dose at least 4 weeks after the first dose</spannedText>
        <creationDate>Tue Apr 03 08:36:24 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3382">
        <mentionClass id="claim">Children who previously received a single dose of MMR vaccine should receive a second dose at least 4 weeks after the first dose</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3383" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="31285" end="31387" />
        <spannedText>Measles-susceptible adolescents should receive two doses of MMR vaccine given at least 4 weeks apart</spannedText>
        <creationDate>Tue Apr 03 08:41:08 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3383">
        <mentionClass id="claim">Measles-susceptible adolescents should receive two doses of MMR vaccine given at least 4 weeks apart</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3384" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="31427" end="31561" />
        <spannedText>Measles-susceptible adults should receive one or two doses of MMR vaccine as appropriate for age and risk factors (refer to Table 1)</spannedText>
        <creationDate>Tue Apr 03 08:41:12 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3384">
        <mentionClass id="claim">Measles-susceptible adults should receive one or two doses of MMR vaccine as appropriate for age and risk factors (refer to Table 1)</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3385" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="31563" end="31672" />
        <spannedText>If two doses are needed, MMR vaccine should be administered with a minimum interval of 4 weeks between doses</spannedText>
        <creationDate>Tue Apr 03 08:41:17 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3385">
        <mentionClass id="claim">If two doses are needed, MMR vaccine should be administered with a minimum interval of 4 weeks between doses</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3386" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="32378" end="32470" />
        <spannedText>The diluent may be stored in the refrigerator or at room temperature and must not be frozen</spannedText>
        <creationDate>Tue Apr 03 08:41:37 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3386">
        <mentionClass id="claim">The diluent may be stored in the refrigerator or at room temperature and must not be frozen</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3387" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="32483" end="32522" />
        <spannedText>Store in a refrigerator at +2°C to +8°C</spannedText>
        <creationDate>Tue Apr 03 08:41:51 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3387">
        <mentionClass id="claim">Store in a refrigerator at +2°C to +8°C</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3388" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="32583" end="32601" />
        <spannedText>Protect from light</spannedText>
        <creationDate>Tue Apr 03 08:41:55 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3388">
        <mentionClass id="claim">Protect from light</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3389" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="32620" end="32702" />
        <spannedText>Store the vaccine and diluent in a refrigerator at +2°C to +8°C and do not freeze</spannedText>
        <creationDate>Tue Apr 03 08:41:58 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3389">
        <mentionClass id="claim">Store the vaccine and diluent in a refrigerator at +2°C to +8°C and do not freeze</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3390" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="32704" end="32734" />
        <spannedText>Protect the vaccine from light</spannedText>
        <creationDate>Tue Apr 03 08:42:00 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3390">
        <mentionClass id="claim">Protect the vaccine from light</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3391" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="33119" end="33294" />
        <spannedText>In general, if two live parenteral vaccines are not administered concomitantly, there should be a period of at least 4 weeks before the second live parenteral vaccine is given</spannedText>
        <creationDate>Tue Apr 03 08:42:10 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3391">
        <mentionClass id="claim">In general, if two live parenteral vaccines are not administered concomitantly, there should be a period of at least 4 weeks before the second live parenteral vaccine is given</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3392" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="33626" end="33794" />
        <spannedText>do not concomitantly administer varicella-containing vaccines with smallpox vaccine; administer varicella-containing vaccine and smallpox vaccine at least 4 weeks apart</spannedText>
        <creationDate>Tue Apr 03 08:43:34 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3392">
        <mentionClass id="claim">do not concomitantly administer varicella-containing vaccines with smallpox vaccine; administer varicella-containing vaccine and smallpox vaccine at least 4 weeks apart</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3393" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="34136" end="34262" />
        <spannedText>Adverse events following MMR immunization occur less frequently and are less severe than those associated with natural disease</spannedText>
        <creationDate>Tue Apr 03 08:43:44 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3393">
        <mentionClass id="claim">Adverse events following MMR immunization occur less frequently and are less severe than those associated with natural disease</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3394" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="36363" end="36475" />
        <spannedText>The potential risk to benefit ratio should be carefully evaluated before considering vaccination in such cases</spannedText>
        <creationDate>Tue Apr 03 08:45:13 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3394">
        <mentionClass id="claim">The potential risk to benefit ratio should be carefully evaluated before considering vaccination in such cases</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3395" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="40399" end="40546" />
        <spannedText>For all vaccines, immunization should always be performed by personnel with the capability and facilities to manage adverse events post-vaccination</spannedText>
        <creationDate>Tue Apr 03 08:46:34 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3395">
        <mentionClass id="claim">For all vaccines, immunization should always be performed by personnel with the capability and facilities to manage adverse events post-vaccination</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3396" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="41545" end="41640" />
        <spannedText>Administration of MMR or MMRV vaccine should be postponed in persons with severe acute illness</spannedText>
        <creationDate>Tue Apr 03 08:47:13 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3396">
        <mentionClass id="claim">Administration of MMR or MMRV vaccine should be postponed in persons with severe acute illness</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3397" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="42092" end="42294" />
        <spannedText>Systemic antiviral therapy (such as acyclovir, valacyclovir, famciclovir) should be avoided in the peri-immunization period, as it may reduce the efficacy of varicella-containing vaccine such as MMRV</spannedText>
        <creationDate>Tue Apr 03 08:48:00 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3397">
        <mentionClass id="claim">Systemic antiviral therapy (such as acyclovir, valacyclovir, famciclovir) should be avoided in the peri-immunization period, as it may reduce the efficacy of varicella-containing vaccine such as MMRV</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3398" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="42296" end="42562" />
        <spannedText>On the basis of expert opinion, it is recommended that people taking long-term antiviral therapy should discontinue these drugs, if possible, from at least 24 hours before administration of MMRV vaccine and should not restart antiviral therapy until 14 days after</spannedText>
        <creationDate>Tue Apr 03 08:48:15 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3398">
        <mentionClass id="claim">On the basis of expert opinion, it is recommended that people taking long-term antiviral therapy should discontinue these drugs, if possible, from at least 24 hours before administration of MMRV vaccine and should not restart antiviral therapy until 14 days after</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3399" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="42704" end="42903" />
        <spannedText>If tuberculin skin testing or an Interferon Gamma Release Assay (IGRA) test is required, it should be done on the same day as immunization or delayed for at least 4 weeks after measles vaccination</spannedText>
        <creationDate>Tue Apr 03 08:48:25 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3399">
        <mentionClass id="claim">If tuberculin skin testing or an Interferon Gamma Release Assay (IGRA) test is required, it should be done on the same day as immunization or delayed for at least 4 weeks after measles vaccination</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3400" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="43173" end="43369" />
        <spannedText>These vaccines should be given at least 14 days prior to administration of an Ig preparation or blood product, or delayed until the antibodies in the Ig preparation or blood product have degraded</spannedText>
        <creationDate>Tue Apr 03 08:48:37 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3400">
        <mentionClass id="claim">These vaccines should be given at least 14 days prior to administration of an Ig preparation or blood product, or delayed until the antibodies in the Ig preparation or blood product have degraded</mentionClass>
    </classMention>
    <annotation>
        <mention id="EHOST_Instance_3401" />
        <annotator id="eHOST_2010">Benedetta</annotator>
        <span start="43751" end="43894" />
        <spannedText>If the vaccine is given too early following Ig or blood product administration, it should be repeated after the appropriate interval has passed</spannedText>
        <creationDate>Tue Apr 03 08:49:29 MDT 2018</creationDate>
    </annotation>
    <classMention id="EHOST_Instance_3401">
        <mentionClass id="claim">If the vaccine is given too early following Ig or blood product administration, it should be repeated after the appropriate interval has passed</mentionClass>
    </classMention>
    <eHOST_Adjudication_Status version="1.0">
        <Adjudication_Selected_Annotators version="1.0" />
        <Adjudication_Selected_Classes version="1.0" />
        <Adjudication_Others>
            <CHECK_OVERLAPPED_SPANS>false</CHECK_OVERLAPPED_SPANS>
            <CHECK_ATTRIBUTES>false</CHECK_ATTRIBUTES>
            <CHECK_RELATIONSHIP>false</CHECK_RELATIONSHIP>
            <CHECK_CLASS>false</CHECK_CLASS>
            <CHECK_COMMENT>false</CHECK_COMMENT>
        </Adjudication_Others>
    </eHOST_Adjudication_Status>
</annotations>

